{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T14:05:08Z","timestamp":1746885908534},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Davita Portugal"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,30]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Patients with chronic kidney disease (CKD) present a higher risk of cardiovascular (CV) morbidity and mortality compared with the general population. While there are several well-established traditional CV risk factors, few studies have addressed novel potential risk factors such as \u03b1-Klotho, asymmetric dimethylarginine (ADMA) and lean mass.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>This was an observational, prospective, single-center, cohort study that included prevalent hemodialysis (online hemodiafiltration) adult patients. By univariate logistic regression models, univariate and multivariate Cox proportional hazards models, and Kaplan\u2013Meier analysis, we evaluated the association between the levels of \u03b1-Klotho, ADMA and lean mass, with the risk of peripheral vascular disease (PVD), CV events and all-cause mortality in these patients.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 200 HD patients was included. We found that increased levels of log-\u03b1-Klotho were significantly associated with decreased odds of both PVD [odds ratio (OR) 0.521, 95% confidence interval (CI) 0.270\u20130.954, P\u00a0=\u00a0.034] and CV events (OR 0.415, 95% CI 0.203\u20130.790, P\u00a0=\u00a0.01), whereas increased levels of log-ADMA were only significantly associated with increased odds of PVD (OR 13.482, 95% CI 5.055\u201341.606, P\u00a0&amp;lt;\u00a0.001). We also found that the levels of log-\u03b1-Klotho (HR 0.357, 95% CI 0.140\u20130.906, P\u00a0&amp;lt;\u00a0.05) and lean mass (HR 0.187, 95% CI 0.042\u20130.829, P\u00a0&amp;lt;\u00a0.05), but not log-ADMA, were significantly associated with the risk of all-cause mortality, even after adjusting for possible confounding variables.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Novel long-term clinical associations were generated that support \u03b1-Klotho and lean mass as novel CV risk factors in hemodialysis patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ckj\/sfad166","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T05:14:07Z","timestamp":1695878047000},"page":"2587-2596","source":"Crossref","is-referenced-by-count":6,"title":["Klotho and lean mass as novel cardiovascular risk factors in hemodialysis patients"],"prefix":"10.1093","volume":"16","author":[{"given":"Ana Rita","family":"Martins","sequence":"first","affiliation":[{"name":"Nephrology Department, Hospital Santa Cruz, Western Lisbon Hospital Centre , Lisbon , Portugal"},{"name":"Institute of Pharmacology, Faculty of Medicine, University of Lisbon , Lisbon , Portugal"}]},{"given":"Sofia","family":"Azeredo-Lopes","sequence":"additional","affiliation":[{"name":"Comprehensive Health Research Centre (CHRC), NOVA Medical School, Nova University Lisbon , Lisbon , Portugal"},{"name":"Department of Statistics and Operational Research, Faculty of Sciences, University of Lisbon , Lisbon , Portugal"}]},{"given":"Sofia Azeredo","family":"Pereira","sequence":"additional","affiliation":[{"name":"iNOVA4Health, LS4future, NOVA Medical School|Faculdade de Ci\u00eancias M\u00e9dicas, NMS|FCM, Universidade Nova de Lisboa , Lisboa , Portugal"},{"name":"Centro Cl\u00ednico Acad\u00e9mico de Lisboa , Lisboa , Portugal"}]},{"given":"In\u00eas","family":"Moreira","sequence":"additional","affiliation":[{"name":"Davita, \u00d3bidos , Portugal"}]},{"given":"Andr\u00e9 Lu\u00edz","family":"Weigert","sequence":"additional","affiliation":[{"name":"Nephrology Department, Hospital Santa Cruz, Western Lisbon Hospital Centre , Lisbon , Portugal"},{"name":"Institute of Pharmacology, Faculty of Medicine, University of Lisbon , Lisbon , Portugal"},{"name":"Davita, \u00d3bidos , Portugal"}]}],"member":"286","published-online":{"date-parts":[[2023,9,27]]},"reference":[{"key":"2023120101530860500_bib1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"Jager","year":"2019","journal-title":"Kidney Int"},{"key":"2023120101530860500_bib2","doi-asserted-by":"crossref","first-page":"S105","DOI":"10.1046\/j.1523-1755.63.s85.25.x","article-title":"Traditional and emerging cardiovascular risk factors in end-stage renal disease","volume":"63","author":"Zoccali","year":"2003","journal-title":"Kidney Int"},{"key":"2023120101530860500_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semnephrol.2016.12.002","article-title":"Evolution of cardiovascular disease during the transition to end-stage renal disease","volume":"37","author":"Bansal","year":"2017","journal-title":"Semin Nephrol"},{"key":"2023120101530860500_bib4","doi-asserted-by":"crossref","first-page":"iii28","DOI":"10.1093\/ndt\/gfy174","article-title":"Cardiovascular disease in dialysis patients","volume":"33","author":"Cozzolino","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"2023120101530860500_bib5","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1523-1755.2000.00173.x","article-title":"Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients","volume":"58","author":"Cheung","year":"2000","journal-title":"Kidney Int"},{"key":"2023120101530860500_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"2023120101530860500_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-019-1391-1","article-title":"Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis","volume":"20","author":"Memmos","year":"2019","journal-title":"BMC Nephrol"},{"key":"2023120101530860500_bib8","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.3390\/jcm9082359","article-title":"Endothelial dysfunction in chronic kidney disease, from biology to clinical outcomes: a 2020 update","volume":"9","author":"Roumeliotis","year":"2020","journal-title":"J Clin Med"},{"key":"2023120101530860500_bib9","doi-asserted-by":"crossref","first-page":"e93423","DOI":"10.1371\/journal.pone.0093423","article-title":"Direct, acute effects of Klotho and FGF23 on vascular smooth muscle and endothelium","volume":"9","author":"Six","year":"2014","journal-title":"PLoS One"},{"key":"2023120101530860500_bib10","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1210\/jc.2017-00104","article-title":"Circulating Klotho associates with cardiovascular morbidity and mortality during hemodialysis","volume":"102","author":"Mar\u00e7ais","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2023120101530860500_bib11","doi-asserted-by":"crossref","first-page":"204062232094017","DOI":"10.1177\/2040622320940176","article-title":"The prognostic value of soluble Klotho in patients with haemodialysis: a systematic review and meta-analysis","volume":"11","author":"Liu","year":"2020","journal-title":"Ther Adv Chronic Dis"},{"key":"2023120101530860500_bib12","doi-asserted-by":"crossref","first-page":"406269","DOI":"10.1155\/2015\/406269","article-title":"Association between serum soluble Klotho levels and mortality in chronic hemodialysis patients","volume":"2015","author":"Otani-Takei","year":"2015","journal-title":"Int J Endocrinol"},{"key":"2023120101530860500_bib13","doi-asserted-by":"crossref","first-page":"e100688","DOI":"10.1371\/journal.pone.0100688","article-title":"Prognostic value and link to atrial fibrillation of soluble klotho and FGF23 in hemodialysis patients","volume":"9","author":"Nowak","year":"2014","journal-title":"PLoS One"},{"key":"2023120101530860500_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1556\/2060.2020.00026","article-title":"Pro- and anti-inflammatory factors, vascular stiffness and outcomes in chronic hemodialysis patients","volume":"107","author":"S\u00e1gi","year":"2020","journal-title":"Physiol Int"},{"key":"2023120101530860500_bib15","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.3390\/ijms20153668","article-title":"Asymmetric (ADMA) and symmetric (SDMA) dimethylarginines in chronic kidney disease: a clinical approach","volume":"20","author":"Oliva-Damaso","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2023120101530860500_bib16","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2174\/1570161114666160112142403","article-title":"Evaluation of endothelial (dys)function, left ventricular structure and function in patients with chronic kidney disease","volume":"14","author":"Bartnicki","year":"2016","journal-title":"Curr Vasc Pharmacol"},{"key":"2023120101530860500_bib17","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/0140-6736(92)90865-Z","article-title":"Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure","volume":"339","author":"Vallance","year":"1992","journal-title":"Lancet"},{"key":"2023120101530860500_bib18","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1681\/ASN.2005010076","article-title":"Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: a competing risks modeling approach","volume":"16","author":"Ravani","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"2023120101530860500_bib19","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000135655","article-title":"Oxidative stress and asymmetric dimethylarginine are associated with cardiovascular complications in hemodialysis patients: improvements by L-arginine intake","volume":"31","author":"El-Mesallamy","year":"2008","journal-title":"Kidney Blood Press Res"},{"key":"2023120101530860500_bib20","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/S0140-6736(01)07217-8","article-title":"Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study","volume":"358","author":"Zoccali","year":"2001","journal-title":"Lancet"},{"key":"2023120101530860500_bib21","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1053\/j.ajkd.2006.08.003","article-title":"Association of homocysteine and asymmetric dimethylarginine with atherosclerosis and cardiovascular events in maintenance hemodialysis patients","volume":"48","author":"Kumagai","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2023120101530860500_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.ajkd.2016.10.033","article-title":"Serum asymmetric and symmetric dimethylarginine and morbidity and mortality in hemodialysis patients","volume":"70","author":"Shafi","year":"2017","journal-title":"Am J Kidney Dis"},{"key":"2023120101530860500_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1053\/j.jrn.2015.10.005","article-title":"Body composition and mortality predictors in hemodialysis patients","volume":"26","author":"Caetano","year":"2016","journal-title":"J Ren Nutr"},{"key":"2023120101530860500_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1053\/j.jrn.2015.07.003","article-title":"Lean body mass and survival in hemodialysis patients and the roles of race and ethnicity","volume":"26","author":"Wang","year":"2016","journal-title":"J Ren Nutr"},{"key":"2023120101530860500_bib25","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/HYPERTENSIONAHA.110.160747","article-title":"Diagnosing obesity by body mass index in chronic kidney disease","volume":"56","author":"Agarwal","year":"2010","journal-title":"Hypertension"},{"key":"2023120101530860500_bib26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000492939","article-title":"Fat-to-lean mass ratio can predict cardiac events and all-cause mortality in patients undergoing hemodialysis","volume":"73","author":"Lee","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"2023120101530860500_bib27","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/ki.2009.524","article-title":"Both low muscle mass and low fat are associated with higher all-cause mortality in hemodialysis patients","volume":"77","author":"Huang","year":"2010","journal-title":"Kidney Int"},{"key":"2023120101530860500_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/0886022X.2018.1456451","article-title":"Low lean tissue mass can be a predictor of one-year survival in hemodialysis patients","volume":"40","author":"Rymarz","year":"2018","journal-title":"Ren Fail"},{"key":"2023120101530860500_bib29","article-title":"survminer: drawing survival curves using \u2018ggplot2\u2019","author":"Kassambara","year":"2020"},{"key":"2023120101530860500_bib30","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4419-6646-9","author":"Kleinbaum","year":"2012","journal-title":"Survival Analysis: A Self-Learning Text"},{"key":"2023120101530860500_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2307\/2532740","article-title":"Maximally selected rank statistics","volume":"48","author":"Lausen","year":"1992","journal-title":"Biometrics"},{"key":"2023120101530860500_bib32","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood-2012-03-415588","article-title":"Clinical and prognostic role of annexin A2 in multiple myeloma","volume":"120","author":"Seckinger","year":"2012","journal-title":"Blood"},{"key":"2023120101530860500_bib33","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.18632\/oncotarget.1740","article-title":"A DNA repair pathway score predicts survival in human multiple myeloma: the potential for therapeutic strategy","volume":"5","author":"Kassambara","year":"2014","journal-title":"Oncotarget"},{"key":"2023120101530860500_bib34","author":"R Core Team","year":"2020","journal-title":"R: A Language and Environment for Statistical Computing"},{"key":"2023120101530860500_bib35","article-title":"A package for survival","author":"Therneau","year":"2020"},{"key":"2023120101530860500_bib36","author":"Therneau","year":"2000","journal-title":"Modeling Survival Data: Extending the Cox Model"},{"key":"2023120101530860500_bib37","doi-asserted-by":"crossref","first-page":"e0177493","DOI":"10.1371\/journal.pone.0177493","article-title":"The issue of plasma asymmetric dimethylarginine reference range - a systematic review and meta-analysis","volume":"12","author":"N\u00e9meth","year":"2017","journal-title":"PLoS One"},{"key":"2023120101530860500_bib38","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.3390\/jcm11092415","article-title":"References values of soluble \u03b1-klotho serum levels using an enzyme-linked immunosorbent assay in healthy adults aged 18-85 years","volume":"11","author":"Espuch-Oliver","year":"2022","journal-title":"J Clin Med"},{"key":"2023120101530860500_bib39","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s11255-020-02510-1","article-title":"Lower circulating soluble Klotho level is associated with increased risk of all-cause mortality in chronic kidney disease patients: a systematic review and meta-analysis","volume":"52","author":"Charoenngam","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"2023120101530860500_bib40","first-page":"510","article-title":"Relationship between serum soluble Klotho protein and coronary artery calcification and prognosis in patients on maintenance hemodialysis","volume":"47","author":"Zheng","year":"2018;","journal-title":"Iran J Public Health"},{"key":"2023120101530860500_bib41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exger.2019.05.003","article-title":"Physical performance, plasma S-klotho, and all-cause mortality in elderly dialysis patients: a prospective cohort study","volume":"122","author":"Valenzuela","year":"2019","journal-title":"Exp Gerontol"},{"key":"2023120101530860500_bib42","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1681\/ASN.2014040325","article-title":"Soluble klotho protects against uremic cardiomyopathy independently of fibroblast growth factor 23 and phosphate","volume":"26","author":"Xie","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"2023120101530860500_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3389\/fendo.2017.00323","article-title":"New insights into the mechanism of action of soluble klotho","volume":"8","author":"Dalton","year":"2017","journal-title":"Front Endocrinol"},{"key":"2023120101530860500_bib44","doi-asserted-by":"crossref","first-page":"931746","DOI":"10.3389\/fphar.2022.931746","article-title":"The controversy of klotho as a potential biomarker in chronic kidney disease","volume":"13","author":"Yu","year":"2022","journal-title":"Front Pharmacol"},{"key":"2023120101530860500_bib45","first-page":"616","article-title":"Asymmetric dimethylarginine, vascular calcifications and parathyroid hormone serum levels in hemodialysis patients","volume":"22","author":"Coen","year":"2009","journal-title":"J Nephrol"},{"key":"2023120101530860500_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/sj.ki.5000331","article-title":"Body fat mass and lean mass as predictors of survival in hemodialysis patients","volume":"70","author":"Kakiya","year":"2006","journal-title":"Kidney Int"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfad166\/51882589\/sfad166.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/12\/2587\/53959928\/sfad166.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/16\/12\/2587\/53959928\/sfad166.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T01:54:14Z","timestamp":1701395654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/16\/12\/2587\/7284413"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,27]]},"references-count":46,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,9,27]]},"published-print":{"date-parts":[[2023,11,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfad166","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,12]]},"published":{"date-parts":[[2023,9,27]]}}}